ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 128 filers reported holding ACCELERATE DIAGNOSTICS INC in Q2 2020. The put-call ratio across all filers is 1.06 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $21,951 | -67.0% | 31,359 | -66.8% | 0.00% | – |
| Q4 2022 | $66,593 | -79.8% | 94,324 | -56.5% | 0.00% | -100.0% |
| Q3 2022 | $329,000 | -9.1% | 216,738 | -13.9% | 0.00% | 0.0% |
| Q1 2022 | $362,000 | -76.6% | 251,691 | -15.1% | 0.00% | -66.7% |
| Q4 2021 | $1,548,000 | +1910.4% | 296,543 | +2141.6% | 0.00% | – |
| Q3 2021 | $77,000 | -83.3% | 13,229 | -76.2% | 0.00% | -100.0% |
| Q1 2021 | $462,000 | -71.9% | 55,470 | -74.4% | 0.00% | -80.0% |
| Q4 2020 | $1,645,000 | +255.3% | 217,002 | +399.6% | 0.01% | +150.0% |
| Q3 2020 | $463,000 | +22.8% | 43,434 | +74.6% | 0.00% | 0.0% |
| Q2 2020 | $377,000 | -69.4% | 24,882 | -83.2% | 0.00% | -80.0% |
| Q1 2020 | $1,233,000 | +38.4% | 148,055 | +180.7% | 0.01% | +233.3% |
| Q4 2019 | $891,000 | – | 52,737 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 2,067,560 | $53,364,000 | 28.19% |
| Selkirk Management LLC | 208,000 | $5,368,000 | 2.94% |
| Iguana Healthcare Management, LLC | 270,000 | $6,969,000 | 2.20% |
| Opaleye Management Inc. | 100,600 | $2,596,000 | 1.03% |
| Miura Global Management | 600,000 | $15,486,000 | 0.94% |
| DSC Advisors, L.P. | 57,400 | $1,481,000 | 0.77% |
| Cannell & Co. | 1,016,828 | $26,244,000 | 0.74% |
| OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | 276,549 | $7,138,000 | 0.61% |
| Harvest Capital Strategies LLC | 100,000 | $2,581,000 | 0.33% |
| Raging Capital Management, LLC | 93,932 | $2,424,000 | 0.31% |